Expanded Access Protocol (EAP) of Idebenone in Patients With Duchenne Muscular Dystrophy

Trial Profile

Expanded Access Protocol (EAP) of Idebenone in Patients With Duchenne Muscular Dystrophy

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 19 Feb 2018

At a glance

  • Drugs Idebenone (Primary)
  • Indications Duchenne muscular dystrophy
  • Focus Expanded access; Therapeutic Use
  • Acronyms BreatheDMD
  • Sponsors Santhera Pharmaceuticals
  • Most Recent Events

    • 08 Feb 2018 Status changed from not yet recruiting to recruiting.
    • 07 Feb 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top